A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Front. Endocrinol., 12 September 2023Sec. Thyroid EndocrinologyVolume 14 - 2023 Clinical management of papillary thyroid cancer depends on estimations of prognosis. Standard care, which relies on prognostication based on clinicopathologic…

Continue ReadingA clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Dr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists

Dr. Cynthia Stretch (Chief Scientific Officer) presented details on the molecular features of molecular subgroups of papillary thyroid cancer that are identifiable using Thyroid GuidePx™ at the Annual Meeting of…

Continue ReadingDr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists

Qualisure submits an international PCT patent application for the molecular subclassification of papillary thyroid cancer

Qualisure has submitted an international PCT patent application for the molecular subclassification of papillary thyroid cancer which is ending review. The Patent Cooperation treaty (PCT) is an international treaty with…

Continue ReadingQualisure submits an international PCT patent application for the molecular subclassification of papillary thyroid cancer